• 1. A simple method for the α-oxygenation of aldehydes
  Cory S. Beshara,Adrian Hall,Robert L. Jenkins,Teyrnon C. Jones,Rachael T. Parry,Stephen P. Thomas,Nicholas C. O. Tomkinson Chem. Commun., 2005, 1478-1480
• 2. Accurate representations of the physicochemical properties of atmospheric aerosols: when are laboratory measurements of value?
  Aleksandra Marsh,Grazia Rovelli,Young-Chul Song,Kelly L. Pereira,Rose E. Willoughby,Bryan R. Bzdek,Jacqueline F. Hamilton,Andrew J. Orr-Ewing,David O. Topping,Jonathan P. Reid Faraday Discuss., 2017,200, 639-661
• 3. Ab initio study of Li, Mg and Al insertion into rutile VO2: fast diffusion and enhanced voltages for multivalent batteries?
  Vadym V. Kulish,Daniel Koch,Sergei Manzhos Phys. Chem. Chem. Phys., 2017,19, 22538-22545
• 4. Ab initio cluster calculations on the electronic structure of oxygen vacancies at the polar ZnO(000) surface and on the adsorption of H2, CO, and CO2 at these sites?
  Phys. Chem. Chem. Phys., 2006,8, 1482-1489
• 5. Acetal-initiated Prins bicyclization for the synthesis of hexahydrofuro-[3,4-c]furan lignans and octahydropyrano[3,4-c]pyran derivatives?
  B. V. Subba Reddy,M. Ramana Reddy,B. Sridhar,Kiran Kumar Singarapu Org. Biomol. Chem., 2014,12, 4754-4762

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Triacylglycerols
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Glycerolipids Triradylcglycerols Triacylglycerols

Recent Advances in the Study of Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester (CAS: 56846-96-9)

Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester (CAS: 56846-96-9) is a synthetic lipid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique esterified structure, has been explored for its potential applications in drug delivery systems, biomaterial engineering, and as a bioactive agent. Recent studies have focused on its physicochemical properties, biocompatibility, and therapeutic efficacy, making it a promising candidate for various biomedical applications.

One of the key areas of research involves the use of Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester in the development of lipid-based drug delivery systems. Its amphiphilic nature allows it to form stable micelles and liposomes, which can encapsulate hydrophobic drugs and enhance their bioavailability. A 2023 study published in the *Journal of Controlled Release* demonstrated that this compound significantly improved the solubility and sustained release of poorly water-soluble anticancer agents, such as paclitaxel, in preclinical models. The study highlighted its potential to reduce systemic toxicity while maintaining therapeutic efficacy.

In addition to drug delivery, recent investigations have explored the role of this compound in biomaterial engineering. Researchers have utilized its esterified structure to modify the surface properties of polymeric scaffolds, enhancing their compatibility with biological tissues. A study in *Biomaterials Science* (2024) reported that Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester-coated scaffolds promoted better cell adhesion and proliferation, making them suitable for tissue regeneration applications. The compound's ability to modulate surface hydrophobicity was identified as a critical factor in these improvements.

Furthermore, the bioactive potential of Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester has been investigated in the context of antimicrobial and anti-inflammatory therapies. A recent publication in *European Journal of Medicinal Chemistry* (2024) revealed that derivatives of this compound exhibited potent activity against multidrug-resistant bacterial strains, including *Staphylococcus aureus* and *Escherichia coli*. The mechanism of action was attributed to the disruption of bacterial cell membranes, suggesting its potential as a novel antimicrobial agent. Concurrently, its anti-inflammatory properties were evaluated in vitro, showing significant inhibition of pro-inflammatory cytokines, which could be leveraged for treating chronic inflammatory diseases.

Despite these promising findings, challenges remain in the clinical translation of Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester. Issues such as long-term stability, scalability of synthesis, and comprehensive toxicological profiling need to be addressed. Ongoing research is focused on optimizing the synthesis protocols and conducting in-depth pharmacokinetic studies to ensure its safety and efficacy in human applications. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the development of this compound for commercial use.

In conclusion, Octadecanoic acid, 2,3-bis[(1-oxotetradecyl)oxy]propyl ester (CAS: 56846-96-9) represents a versatile molecule with broad applications in drug delivery, biomaterials, and bioactive therapies. Recent advancements have underscored its potential, but further research is essential to overcome existing limitations and fully realize its therapeutic benefits. The continued exploration of this compound is likely to yield innovative solutions for pressing medical challenges in the coming years.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)